Immunoglobulin G4-related sclerosing cholangitis mimicking cholangiocarcinoma: a case report and literature review
- PMID: 33025818
- PMCID: PMC7545771
- DOI: 10.1177/0300060520959214
Immunoglobulin G4-related sclerosing cholangitis mimicking cholangiocarcinoma: a case report and literature review
Abstract
Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a novel clinical disease that is characterized by elevated serum IgG4 concentrations and tumefaction or tissue infiltrated by IgG4+ plasma cells. The clinical manifestations of IgG4-RD depend on the type of tissues affected. IgG4-related sclerosing cholangitis is a type of IgG4-RD. We report a patient who initially visited a local hospital with a 5-month history of jaundice. He was found to have a mass in the upper part of the common bile duct that mimicked cholangiocarcinoma. He underwent surgery in our hospital and was later diagnosed with IgG4-related sclerosing cholangitis. We administered prednisolone 40 mg once a day for treatment. Taking into account the possible side effects of moderate-dose hormone therapy, we also administered teprenone, potassium chloride, and calcium carbonate. The patient did not have any recurrence of symptoms or adverse drug reactions during follow-up.
Keywords: IgG4-related disease; cholangiocarcinoma; common bile duct; jaundice; prednisone; sclerosing cholangitis.
Figures





Similar articles
-
Immunoglobulin G4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma diagnosed with following bile duct resection: report of a case.Int Surg. 2015 Mar;100(3):480-5. doi: 10.9738/INTSURG-D-14-00230.1. Int Surg. 2015. PMID: 25785331 Free PMC article.
-
Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis?Gastrointest Endosc. 2005 Jul;62(1):152-7. doi: 10.1016/s0016-5107(05)00561-4. Gastrointest Endosc. 2005. PMID: 15990840
-
Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.J Gastroenterol Hepatol. 2010 Dec;25(12):1831-7. doi: 10.1111/j.1440-1746.2010.06411.x. J Gastroenterol Hepatol. 2010. PMID: 21091993
-
Significant CA 19-9 elevation in IgG4-related autoimmune pancreatitis - A diagnostic dilemma.Am J Med Sci. 2024 Jan;367(1):67-71. doi: 10.1016/j.amjms.2023.09.016. Epub 2023 Sep 14. Am J Med Sci. 2024. PMID: 37714269 Review.
-
Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature.Am J Med Sci. 2022 Sep;364(3):359-365. doi: 10.1016/j.amjms.2022.04.016. Epub 2022 Apr 22. Am J Med Sci. 2022. PMID: 35469769 Review.
References
-
- Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease. Lancet 2015; 385: 1460–1471. - PubMed
-
- Tanaka A, Tazuma S, Okazaki K, et al. Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis. Clin Gastroenterol Hepatol 2017; 15: 920–926.e3. - PubMed
-
- Khosroshahi A, Wallace ZS, Crowe JL, et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol 2015; 67: 1688–1699. - PubMed
-
- Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012; 22: 21–30. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous